COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM LONG; STENT, SUPERFICIAL FEMORAL ARTERY
|
Back to Search Results |
|
Model Number EVD35-06-150-120 |
Device Problems
Difficult to Remove (1528); Activation, Positioning or Separation Problem (2906); Detachment of Device or Device Component (2907); Material Deformation (2976)
|
Patient Problems
Obstruction/Occlusion (2422); Vascular Dissection (3160)
|
Event Date 11/04/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
A physician was implanting an everflex entrust for the treatment of a 130mm calcified lesion with 80% stenosis in the mid superficial femoral artery.There was moderate calcification and tortuosity.The device was prepped as per the ifu with no issues identified.A non-medtronic guidewire was used.No issues noted when removing the device from the hoop/tray.It was reported the pin wheel stopped the deployment of the stent.The physician needed to crack open the handle and deploy the stent manually.The stent elongated and stretched apart inside the vessel.The physician struggled with deploying the remainder of the stent because it had stretched out and elongated.The stent deployed in unintended lesion site.The physician had to complete the procedure by putting in a non-mdt covered stent in the vessel and trap the ever flex and trust behind it.The device was difficult to remove.It was stated that vessel occlusion, dissection and spasm occurred.A detached portion of the device remains in patient.No further patient injury was reported for this event.
|
|
Manufacturer Narrative
|
Product analysis #(b)(6):analysis the device was returned with the red safety tab removed and with several kinks along the outer shaft at approximately 13.5cm from the distally from the strain relief and at approximately 19.6cm, 23.2cm, and 23.8cm from the distal end a 0.035¿ guidewire was loaded through the tip but met resistance, the handle was opened, and it was found that the pullwire had broken and was detached from the inner lumen the outer lumen was skived back, the stent was exposed and confirmed to be 150mm, with no abnormalities noted.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|